Latest Hanger Orthopedic Group (HGR) Headlines
Hanger Downgraded to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 3:41PM CDT
Hanger continues to face macroeconomic headwinds like reimbursement uncertainties, sequestration and RAC audits, which are likely to reduce the bottom line going forward.
10-K: RINGCENTRAL INC
Edgar Online - Wed Feb 26, 5:21AM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
3 Amazing Medical Technologies Developed on Kickstarter and Indiegogo
Leo Sun, The Motley Fool - Motley Fool - Fri Feb 14, 4:12PM CST
Kickstarter, the crowdfunding phenomenon that started nearly five years ago, has funded more than 56,000 projects and raised almost $1 billion to make those dreams come true. About 43.6% of launched projects were successfully funded, and 56 of...
Hanger Unveils WalkAide Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 2:30PM CST
Hanger has announced the publication of the findings from the INSTRIDE WalkAide trial conducted by the company.
Crude Oil Refining Industry in North America: Market Data and Business Intelligence of All Operational and New Build Refineries
PR Newswire - Thu Feb 13, 1:09PM CST
Reportbuyer.com just published a new market research report:
Hanger Q4 Earnings Beat but Flat Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 10:00AM CST
For full year 2013, adjusted earnings per share rose 8.3% to $1.95 from $1.80 a year ago and were in line with the Zacks Consensus Estimate
Hanger announces publication of WalkAide INSTRIDE clinical trial findings and provides update on CMS submission
PR Newswire - Thu Feb 13, 7:14AM CST
Hanger, Inc. (NYSE: HGR) today announced the publication of the findings of the Company's INSTRIDE WalkAide trial in the peer-reviewed journal Neurorehabilitation and Neural Repair. The Company has submitted these findings to the Centers of Medicare and Medicaid Services (CMS) as part of a request for expanded coverage for the WalkAide.
Enerflex to Announce Fourth Quarter and Year End 2013 Financial Results on February 27, 2014
Marketwire Canada - Wed Feb 12, 4:38PM CST
Enerflex Ltd. (TSX:EFX) ("Enerflex" or the "Company"), a leading supplier of products and services to the global energy industry, will release its fourth quarter and year end 2013 financial results on February 27, 2014. These results will be available on the Enerflex website at www.enerflex.com.
Hanger Reports 7% Net Sales Growth and 8% Adjusted Diluted EPS Growth for 2013
PR Newswire - Wed Feb 12, 3:05PM CST
-- Reports 2013 Adjusted Diluted EPS of $1.95
Weakness Seen in Hanger (HGR) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 7:40AM CST
Hanger has witnessed a significant price decline in the past four weeks along with a negative trend in earnings estimate revisions
Hanger Announces Appointment of Richard Pettingill to Board of Directors
PR Newswire - Mon Feb 10, 3:05PM CST
Hanger, Inc. (NYSE: HGR) today announced that its Board of Directors elected Richard Pettingill, retired President and Chief Executive Officer of Allina Hospitals and Clinics, a large network of healthcare providers in Minnesota, to the Hanger Board as a director effective February 6, 2014. Mr. Pettingill qualifies as an independent director under applicable New York Stock Exchange listing standards.
Form 4: Update Filing for Hanger Inc (HGR)
Vickers Stock Research - Fri Feb 07, 5:30AM CST
SHELTON, CT. (February 7, 2013) - The Board of Directors of Hubbell Incorporated (NYSE: HUBA, HUBB) today declared a regular quarterly dividend of $0.45 per share on the Company's Class A and Class B common stock. The dividend will be paid on March 15, 2013 to shareholders of record on March 1, 2013.
NYSE stocks posting largest volume increases
AP - Fri Jan 31, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
NYSE stocks posting largest percentage decreases
AP - Fri Jan 31, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
Glancy Binkow & Goldberg LLP Announces Investigation of Hanger, Inc.
Business Wire - Fri Jan 31, 2:02PM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Hanger, Inc. ("Hanger" or the "Company") (NYSE:HGR) concerning possible violations of federal securities laws. The investigation is focused on certain statements issued by Hanger concerning the Company's operations and financial performance.
Why Hanger (HGR) Is Down Today
at The Street - Fri Jan 31, 12:11PM CST
Hanger (HGR) falls after the prosthetic and orthopedics maker lowers earnings guidance for the year. The company says it expects adjusted EPS of between $1.94 and $1.96; it previously expected earnings of $2.08 to $2.11 a share.
Hanger Announces Preliminary Results for Fiscal Year 2013
PR Newswire - Thu Jan 30, 3:05PM CST
Hanger, Inc. (NYSE: HGR) today announced that it anticipates adjusted diluted earnings per share for fiscal year 2013 to be between $1.94 and $1.96, which is below the previous guidance range of $2.08 to $2.11 for adjusted earnings per diluted share provided by the Company on October 29, 2013. On a reported basis, the Company expects earnings per diluted share to be between $1.79 and $1.81. Adjusted earnings per diluted share excludes certain tax benefits, costs of the debt refinance, costs related to acquisitions and costs related to the implementation of the Company's new clinic management system will add approximately $0.15 to earnings per diluted share.
Hanger Orthopedic Has Returned 13.9% Since SmarTrend Recommendation (HGR)
Comtex SmarTrend(R) - Thu Jan 30, 11:17AM CST
SmarTrend identified an Uptrend for Hanger Orthopedic (NYSE:HGR) on October 1st, 2013 at $33.97. In approximately 4 months, Hanger Orthopedic has returned 13.89% as of today's recent price of $38.69.
Hanger Orthopedic Up 16.9% Since SmarTrend Uptrend Call (HGR)
Comtex SmarTrend(R) - Thu Jan 23, 10:02AM CST
SmarTrend identified an Uptrend for Hanger Orthopedic (NYSE:HGR) on October 1st, 2013 at $33.97. In approximately 4 months, Hanger Orthopedic has returned 16.90% as of today's recent price of $39.71.
Hanger Downgraded to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 3:41PM CDT
Hanger continues to face macroeconomic headwinds like reimbursement uncertainties, sequestration and RAC audits, which are likely to reduce the bottom line going forward.
10-K: RINGCENTRAL INC
Edgar Online - Wed Feb 26, 5:21AM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
3 Amazing Medical Technologies Developed on Kickstarter and Indiegogo
Leo Sun, The Motley Fool - Motley Fool - Fri Feb 14, 4:12PM CST
Kickstarter, the crowdfunding phenomenon that started nearly five years ago, has funded more than 56,000 projects and raised almost $1 billion to make those dreams come true. About 43.6% of launched projects were successfully funded, and 56 of...
Hanger Unveils WalkAide Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 2:30PM CST
Hanger has announced the publication of the findings from the INSTRIDE WalkAide trial conducted by the company.
Crude Oil Refining Industry in North America: Market Data and Business Intelligence of All Operational and New Build Refineries
PR Newswire - Thu Feb 13, 1:09PM CST
Reportbuyer.com just published a new market research report:
Hanger Q4 Earnings Beat but Flat Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 10:00AM CST
For full year 2013, adjusted earnings per share rose 8.3% to $1.95 from $1.80 a year ago and were in line with the Zacks Consensus Estimate
Hanger announces publication of WalkAide INSTRIDE clinical trial findings and provides update on CMS submission
PR Newswire - Thu Feb 13, 7:14AM CST
Hanger, Inc. (NYSE: HGR) today announced the publication of the findings of the Company's INSTRIDE WalkAide trial in the peer-reviewed journal Neurorehabilitation and Neural Repair. The Company has submitted these findings to the Centers of Medicare and Medicaid Services (CMS) as part of a request for expanded coverage for the WalkAide.
Enerflex to Announce Fourth Quarter and Year End 2013 Financial Results on February 27, 2014
Marketwire Canada - Wed Feb 12, 4:38PM CST
Enerflex Ltd. (TSX:EFX) ("Enerflex" or the "Company"), a leading supplier of products and services to the global energy industry, will release its fourth quarter and year end 2013 financial results on February 27, 2014. These results will be available on the Enerflex website at www.enerflex.com.
Hanger Reports 7% Net Sales Growth and 8% Adjusted Diluted EPS Growth for 2013
PR Newswire - Wed Feb 12, 3:05PM CST
-- Reports 2013 Adjusted Diluted EPS of $1.95
Weakness Seen in Hanger (HGR) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 7:40AM CST
Hanger has witnessed a significant price decline in the past four weeks along with a negative trend in earnings estimate revisions
Hanger Announces Appointment of Richard Pettingill to Board of Directors
PR Newswire - Mon Feb 10, 3:05PM CST
Hanger, Inc. (NYSE: HGR) today announced that its Board of Directors elected Richard Pettingill, retired President and Chief Executive Officer of Allina Hospitals and Clinics, a large network of healthcare providers in Minnesota, to the Hanger Board as a director effective February 6, 2014. Mr. Pettingill qualifies as an independent director under applicable New York Stock Exchange listing standards.
Form 4: Update Filing for Hanger Inc (HGR)
Vickers Stock Research - Fri Feb 07, 5:30AM CST
SHELTON, CT. (February 7, 2013) - The Board of Directors of Hubbell Incorporated (NYSE: HUBA, HUBB) today declared a regular quarterly dividend of $0.45 per share on the Company's Class A and Class B common stock. The dividend will be paid on March 15, 2013 to shareholders of record on March 1, 2013.
NYSE stocks posting largest volume increases
AP - Fri Jan 31, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
NYSE stocks posting largest percentage decreases
AP - Fri Jan 31, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
Glancy Binkow & Goldberg LLP Announces Investigation of Hanger, Inc.
Business Wire - Fri Jan 31, 2:02PM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Hanger, Inc. ("Hanger" or the "Company") (NYSE:HGR) concerning possible violations of federal securities laws. The investigation is focused on certain statements issued by Hanger concerning the Company's operations and financial performance.
Why Hanger (HGR) Is Down Today
at The Street - Fri Jan 31, 12:11PM CST
Hanger (HGR) falls after the prosthetic and orthopedics maker lowers earnings guidance for the year. The company says it expects adjusted EPS of between $1.94 and $1.96; it previously expected earnings of $2.08 to $2.11 a share.
Hanger Announces Preliminary Results for Fiscal Year 2013
PR Newswire - Thu Jan 30, 3:05PM CST
Hanger, Inc. (NYSE: HGR) today announced that it anticipates adjusted diluted earnings per share for fiscal year 2013 to be between $1.94 and $1.96, which is below the previous guidance range of $2.08 to $2.11 for adjusted earnings per diluted share provided by the Company on October 29, 2013. On a reported basis, the Company expects earnings per diluted share to be between $1.79 and $1.81. Adjusted earnings per diluted share excludes certain tax benefits, costs of the debt refinance, costs related to acquisitions and costs related to the implementation of the Company's new clinic management system will add approximately $0.15 to earnings per diluted share.
Hanger Orthopedic Has Returned 13.9% Since SmarTrend Recommendation (HGR)
Comtex SmarTrend(R) - Thu Jan 30, 11:17AM CST
SmarTrend identified an Uptrend for Hanger Orthopedic (NYSE:HGR) on October 1st, 2013 at $33.97. In approximately 4 months, Hanger Orthopedic has returned 13.89% as of today's recent price of $38.69.
Hanger Orthopedic Up 16.9% Since SmarTrend Uptrend Call (HGR)
Comtex SmarTrend(R) - Thu Jan 23, 10:02AM CST
SmarTrend identified an Uptrend for Hanger Orthopedic (NYSE:HGR) on October 1st, 2013 at $33.97. In approximately 4 months, Hanger Orthopedic has returned 16.90% as of today's recent price of $39.71.
